Michelle Yen1, Junming Ren1, Qingxiang Liu1

  • 1Departments of Molecular and Cellular Physiology, and Structural Biology, Stanford University School of Medicine, Stanford, CA 94305, USA; Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.

Cell
|March 24, 2022
PubMed
概括

研究人员开发了模块化连接体,以创建细胞因子代用激素,克服治疗用途的自然细胞因子限制. 这种方法可以对新型免疫调节剂进行高通量查和工程,包括强大的SARS-CoV-2抑制剂.